Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Gossamer Bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 128 | 1 | 133 | +6 |
| Shares | 54.7M | 840.6K | 58.8M | +4.90M (+9.1%) |
| Value | $687.7M | $10.6M | $664.9M | −$12.3M (−1.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Gossamer Bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kynam Capital Management, LP | 1,016,857 | $11.5M | 6.15% |
| Woodline Partners LP | 977,823 | $11.1M | 0.16% |
| OrbiMed Advisors LLC | 683,000 | $7.72M | 0.10% |
| Lord, Abbett & Co. LLC | 390,146 | $4.41M | 0.01% |
| Walleye Capital LLC | 181,624 | $2.05M | 0.07% |
| Endurant Capital Management LP | 113,660 | $1.28M | 0.35% |
| Barclays PLC | 72,450 | $819.0K | 0.00% |
| Jump Financial, LLC | 48,068 | $544.0K | 0.03% |
| Lazard Asset Management LLC | 44,385 | $501.0K | 0.00% |
| Renaissance Technologies LLC | 43,700 | $494.0K | 0.00% |
| Simplex Trading, LLC | 16,029 | $181.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 14,618 | $165.0K | 0.00% |
| XTX Topco Ltd | 13,310 | $151.0K | 0.09% |
| Belvedere Trading LLC | 14,089 | $145.0K | 0.03% |
| Martingale Asset Management L P | 11,400 | $130.0K | 0.00% |
| Janus Henderson Group PLC | 10,087 | $114.0K | 0.00% |
| Walleye Trading LLC | 7,282 | $82.0K | 0.00% |
| Beaird Harris Wealth Management, LLC | 717 | $8.00K | 0.00% |
| PFS Partners, LLC | 172 | $1.95K | 0.00% |
| Bivin & Associates, Inc. | 70 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 120,066 | $1.51M |
| Hudson Bay Capital Management LP | 78,500 | $987.0K |
| ExodusPoint Capital Management, LP | 36,443 | $458.0K |
| Principal Financial Group Inc | 15,001 | $189.0K |
| Gsa Capital Partners LLP | 10,578 | $133.0K |
| Liberty Wealth Management LLC | 2,000 | $25.0K |
| Penserra Capital Management LLC | 1,735 | $21.0K |
| Lindbrook Capital, LLC | 1,500 | $19.0K |
| Point72 Hong Kong Ltd | 1,378 | $17.0K |
| Alaethes Wealth LLC | 750 | $9.00K |
| Johnson Midwest Financial, LLC | 260 | $3.00K |
| Brewin Dolphin Ltd | 169 | $2.12K |
| Harbour Investments, Inc. | 105 | $1.00K |
| Meridian Wealth Partners, LLC | 20 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 840,642 | $10.6M |